CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-15 | Rodriguez Javier See Remarks | Option exercise | +35 | 6,727 | ||
| 2025-09-15 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −35 | 317 | ||
| 2025-09-15 | Yocca Frank Chief Scientific Officer | Option exercise | +35 | 6,384 | ||
| 2025-09-15 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −35 | 317 | ||
| 2025-09-14 | Mehta Vimal CEO and President | Option exercise | +163 | 20,274 | ||
| 2025-09-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −163 | 816 | ||
| 2025-09-14 | Steinhart Richard I Chief Financial Officer | Option exercise | +33 | 6,474 | ||
| 2025-09-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −33 | 163 | ||
| 2025-09-14 | Rodriguez Javier See Remarks | Option exercise | +33 | 6,692 | ||
| 2025-09-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −33 | 163 | ||
| 2025-09-14 | Yocca Frank Chief Scientific Officer | Option exercise | +33 | 6,349 | ||
| 2025-09-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −33 | 163 | ||
| 2025-08-31 | MACK DAVID J. Director | Option exercise | +1,693 | 16,930 | ||
| 2025-08-31 | MACK DAVID J. Director | Option exercise · Restricted Stock Units | −1,693 | 3,387 | ||
| 2025-08-01 | Steinhart Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +9,000 | 9,000 | ||
| 2025-08-01 | Rodriguez Javier See Remarks | Grant or award · Restricted Stock Units | +9,000 | 9,000 | ||
| 2025-08-01 | Yocca Frank Chief Scientific Officer | Grant or award · Restricted Stock Units | +9,000 | 9,000 | ||
| 2025-08-01 | Mehta Vimal CEO and President | Grant or award · Restricted Stock Units | +18,000 | 18,000 | ||
| 2025-07-31 | MACK DAVID J. Director | Option exercise | +1,693 | 15,237 | ||
| 2025-07-31 | MACK DAVID J. Director | Option exercise · Restricted Stock Units | −1,693 | 5,080 |
Page 5 of 27 · 521 trades